Table 1. . This table describes the clinical features of the patients with primary biliary cholangitis, primary sclerosing cholangitis and controls that were included in the study.
PBC | PSC | ||||
---|---|---|---|---|---|
Control (N = 39) | Case (N = 40) | Control_noIBD (N = 40) | Case_noIBD (N = 38) | Case_IBD (N = 40) | |
Age | |||||
– Mean (SD) | 57.7 (12.0) | 57.3 (12.04) | 51.6 (13.3) | 52.5 (14.4) | 51.4 (13.7) |
– Range | 36.5–81.2 | 37.6–80.7 | 20.1–73.7 | 21.8–80.5 | 20.9–73.7 |
Sex | |||||
– F | 39 (100.0%) | 40 (100.0%) | 23 (57.5%) | 21 (55.3%) | 23 (57.5%) |
– M | 0 (0.0%) | 0 (0.0%) | 17 (42.5%) | 17 (44.7%) | 17 (42.5%) |
IBD: Inflammatory bowel disease; PBC: Primary biliary cholangitis; PSC: Primary sclerosing cholangitis.